Dr. Spencer joined DCA in July 2023, and is responsible for chairing the Company’s Audit and Risk Management Committee. Dr. Spencer has extensive experience in healthcare and life sciences, digital transformation and innovation as well as organisational governance.

Dr. Spencer holds a PHD in Novel therapies for Paediatric Cancers and a General Medical Degree. Dr Spencer has a successful record of transforming and growing business through innovation. She gained her experience through working with fortune 500 companies, including HCA Healthcare, Pfizer and Merck to reshape their strategies; enabling them to transform into patient/consumer experience driven organisations that engage with the Healthcare Providers, Payers, and Patients in an innovative, secure and compliant way. Dr. Spencer spent several years with IBM in the technology and business consulting sector advising a wide range of clients on how to transform their businesses to adapt to changing market conditions, improve efficiency, increase competitiveness, and ultimately deliver better value to customers and shareholders.

Dr. Spencer sits on the board at Optegra International and she led a successful business transformation programme during COVID, focused on pathway standardisation and digital transformation; launching virtual consultations, paperless ways of working, shifting strategy from exclusively private towards a mix of private and publicly-funded surgery. This enabled Optegra to be a profitable and sustainable business, more customer-centric yet highly agile, flexible and innovative.